Speakers

Agnès Bénardeau

Senior Director, Head of Cardio-Renal Biology

Novo Nordisk

Alan Yu

Professor & Kidney Institute Director

University of Kansas Medical Center

Alan Glicklich

Chief Medical Officer

Chinook Therapeutics

Alex Duncan

Chief Scientific Officer

Walden Biosciences

Aliza Thompson

Deputy Director of the Division of Cardiology & Nephrology

FDA

Andrew King

Chief Scientific Officer

Chinook Therapeutics

Anna Reznichenko

Senior Director, Team Lead Experimental Medicine

AstraZeneca

Anthony Johnson

President & Chief Executive Officer

Goldfinch Bio

Brad Rovin

Director, Division of Nephrology

Ohio State University

Bruce Molitoris

Distinguished Professor of Medicine & Physiology

Indiana University

Chirag Parikh

Chirag Parikh

Director, Division of Nephrology

Johns Hopkins University

Cibele Pinto

Director, Global Medical Affairs

Otsuka

Dermot Reilly

Director, Genetics & Translational Biology

Johnson & Johnson

Di Feng

Assistant Professor of Medicine

Harvard Medical School

Fredrik Erlandsson

Vice President, Head of Global Clinical Development

Vifor Pharma

Gary Friedman

Director, Inflammation & Immunology

Pfizer

Hermann Haller

President

MDI Biological Laboratory

Hiddo Heerspink

Professor

University of Groningen

Hideo Makimura

Vice President & Head, Translational & Experimental Medicine, Cardiovascular & Metabolism Therapeutic Area

Johnson & Johnson

Ivan Formentini

Scientific Vice President & Head of Translational Science

Novo Nordisk

Janet van Adelsberg

Vice President, Research & Development

GlaxoSmithKline

Jeff Jacobs

Chief Scientific Officer

Ardelyx

Jeffrey Hafkin

Senior Director

Otsuka

Jerome Rossert

Vice President, Head of Clinical Renal

AstraZeneca

John Liles

Director, Biology

Gilead Sciences

Jonathan Barratt

The Mayer Professor of Renal Medicine

University of Leicester

Joseph Bonventre

Chief of the Division of Renal Medicine & Founding Chief of the Engineering in Medicine Division

Brigham & Women’s Hospital

Julie Lin

Global Project Head, Clinical Development, Rare Diseases & Rare Blood Disorders

Sanofi Genzyme

Julie Williams

Director, Bioscience CKD

AstraZeneca

Kathryn Garner

Principal Scientist

Newcells Biotech

Kerry Willis

Chief Scientific Officer

National Kidney Foundation

Kevin Woollard

Director

AstraZeneca

LaToya Coffey

Senior Director, Global Development Team Leader

Otsuka

LaVarne Burton

President & Chief Executive Officer

American Kidney Fund

Maria Chiara Magnone

Vice President Kidney Diseases & Boston Site Head

Janssen

Marie-Anne Valentin

Global Head Soluble, Biomarker Team

Novartis

Martin Lefkowitz

Vice President, Global Clinical Research & Development

Novartis

Matthew Breyer

Distinguished Scientist

Johnson & Johnson

Meg Jardine

Professor of Medicine

The University of Sydney

Michael Boettger

Vice President, Head Experimental Medicine CV

Bayer

Michael Spigler

Vice President, Patient Services & Kidney Disease Education

American Kidney Fund

Nader Najafian

Executive Director, Clinical Development Sciences

Alexion

Nikolay Nikolov

Director of the Division of Rheumatology & Transplant Medicine

FDA

William Smith

Executive Director, Nephrology Clinical Development Sciences

Alexion

Pernille Laerkegaard Hansen

Executive Director, Head of Bioscience Renal

AstraZeneca

Richard Furie

Chief, Division of Rheumatology

Northwell Health

Richard Nkulikiyinka

Vice President, Head of Therapeutic Area Cardiology & Nephrology

Bayer

Sameer Bansilal

Executive Director, Cardiovascular & Renal

Bayer

Scott Rottinghaus

Vice President & Head Of Clinical Development, Hematology & Nephrology

Alexion Pharmaceuticals

Seemi Khan

Senior Vice President, Chief Medical Officer

Reata Pharmaceuticals

Sven Moosmang

Therapeutic Area Head Translational Medicine & Clinical Pharmacology Cardiometabolism

Boehringer Ingelheim

Uli Broedl

Senior Vice President, Head of Global Clinical Development & Operations

Boehringer Ingelheim

Candace Middlebrooks

Lead Statistical Geneticist

Goldfinch Bio

David Rosenbaum

Chief Development Officer

Ardelyx

Jonathan Himmelfarb

Professor of Medicine

University of Washington

Joseph Stavas

Senior Vice President Clinical Development

ProKidney

Libby Valenti

Head of BioPharma Medical Education

Natera

Maarten Kraan

Chief Medical Officer

AM-Pharma

Matthias Kretzler

Professor of Internal Medicine & Bioinformatics

University of Michigan

Nicole Endlich

Chief Executive Officer

NIPOKA

Sibylle Hauske

Senior Director, Clinical Development, Chronic Kidney Disease

Boehringer Ingelheim

Uptal Patel

Head of Early Clinical Renal, CVRM

AstraZeneca